| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 11 |
| 1 | CYCLOPHOSPHAMIDE | 9 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 4 | MYCOPHENOLATE MOFETIL | 9 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 9 |
| 6 | PREDNISOLONE | 9 |
| 7 | PREDNISOLONE ORAL | 9 |
| 8 | PREDNISOLONE ORAL SOLUTION | 9 |
| 9 | ASPIRIN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENCICLOVIR | 1 | 0.0028 |
| 1 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 2 | OMAVELOXOLONE | 2 | 0.0011 |
| 3 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 4 | DAPRODUSTAT | 1 | 0.0005 |
| 5 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 6 | ZANAMIVIR | 1 | 0.0004 |
| 7 | RALTEGRAVIR | 2 | 0.0004 |
| 8 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 9 | TAMOXIFEN CITRATE | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 9 | 0.0001 |
| 9 | Vitamin D Analog [EPC] | 1 | 0.0001 |